Signal transduction and cellular radiation responses

Radiation Research

Volumn 153, Issue 3, 2000, Pages 245-257

  Schmidt Ullrich, Rupert K ^a   Dent, Paul ^a   Grant, Steven ^a   Mikkelsen, Ross B ^a   Valerie, Kristoffer ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CYTOTOXICITY; DNA DAMAGE; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034059884     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)153[0245:STACRR]2.0.CO;2     Document Type: Review

References (135)

1. J. F. Ward, DNA damage as the cause of ionizing radiation-induced gene activation. Radiat. Res. 138 (Suppl.), S85-S88 (1994).
2. R. Roots and S. Okada, Protection of DNA molecules of cultured mammalian cells from radiation induced single-strand scissions by various alcohols and SH compounds. Int. J. Radiat. Biol. 21, 329-342 (1972).
3. Y. Ibuki and R. Goto, Enhancement of NO production from residual peritoneal macrophages by in vitro irradiation and its relationship to reactive oxygen intermediates. Free Radic. Biol. Med. 22, 1029-1035 (1997).
4. J. S. Beckman and W. H. Koppenol, Nitric oxide, superoxide and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 271, C1424-C1437 (1996).
5. J. P. Crow, Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: Implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1, 145-157 (1997).
6. S. Clutton, K. Townsend, C. Walker, J. Ansell and E. Wright, Radiation-induced genomic instability and persisting oxidative stress in bone marrow cultures. Carcinogenesis 17, 1633-1639 (1996).
7. L. Wu, G. Randers-Pehrson, A. Xu, C. Waldren, Z. Yu and T. K. Hci, Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc. Natl. Acad. Sci. USA 96, 4959-4964 (1999).
8. T. Rossman and E. Goncharova, Spontaneous mutagenesis in mammalian cells is caused mainly by oxidative events and can be blocked by antioxidants and metallothionein. Mutat. Res. 402, 103-110 (1998).
9. P. Narayanan, E. Goodwin and B. Lehnert, Alpha particles initiate biological production of superoxide anions and hydrogen peroxide. Cancer Res. 57, 3963-3971 (1997).
10. A. Morales, M. Miranda, A. Sanchez-Reyes, A. Biete and J. Fernandez-Checa, Oxidative damage of mitochondrial and nuclear DNA induced by IR in human hepatoblastoma cells. Int. J. Radiat. Oncol. Biol. Phys. 42, 191-204 (1998).
11. H. M. Lander, J. S. Ogiste, K. K. Teng and A. Novogrodsky, A p21ras as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270, 21195-21198 (1995).
12. Y. S. Bae, S. W. Kang, M. S. Seo, I. C. Baines, E. Tekle, P. B. Chock and S. G. Rhee, Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272, 217-221 (1997).
13. S. R. Lee, K. S. Kwon, S. R. Kim and S. G. Rhee, Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273, 15366-15372 (1998).
14. H. M. Lander, J. S. Ogiste, S. F. Pearce, R. Levi and A. Novogrodsky, Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270, 7017-7020 (1995).
15. A. Berroud, A. Le Roy and P. Voisin, Membrane oxidative damage induced by ionizing radiation detected by fluorescence polarization. Radiat. Environ. Biophys. 35, 289-295 (1996).
16. B. Ritov, S. Banni, J. C. Yalowich, B. W. Day, H. G. Claycamp, F. P. Corongiu and V. E. Kagan, Non-random peroxidation of different classes of membrane phospholipids in live cells detected by metabolically integrated cis-parinaric acid. Biochim. Biophys. Acta 1283, 127-140 (1996).
17. R. K. Schmidt-Ullrich, K. Valerie, B. Fogleman and J. Walters, The radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Radiat. Res. 145, 81-86 (1996).
18. R. K. Schmidt-Ullrich, R. B. Mikkelsen, P Dent, D. G. Todd, K. Valerie, B. D. Kavanagh, J. N. Contessa, W. K. Rorrer and P. B. Chen, Radiation-induced proliferation of human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 15, 1191-1197 (1997).
19. N. Balaban, J. Moni, M. Shannon, L. Dang, E. Murphy and T. Goldkorn, The effect of ionizing radiation on signal transduction: Antibodies to EGF receptor sensitize A431 cells to radiation. Biochim. Biophys. Acta 1314, 147-156 (1996).
20. C. Rosette and M. Karin, Ultraviolet light and osmotic stress: Activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274, 1194-1197 (1996).
21. Z. Xia, M. Dickens, J. Raingeaud, R. J. Davis and M. E. Greenberg, Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331 (1995).
22. M. Pap and G. M. Cooper, Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 273, 19929-19932 (1998).
23. J. N. Contessa, D. B. Reardon, D. Todd, P. Dent, R. B. Mikkelsen, K. Valerie, G. D. Bowers and R. K. Schmidt-Ullrich, The inducible expression of dominant negative epidermal growth factor receptor CD533 in radiosensitization of human mammary carcinoma cells. Clin. Cancer Res. 5, 405-411 (1999).
24. J. Baselga, L. Norton, J. Albanell, Y. M. Kim and J. Mendelsohn, Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/ neu overexpressing human breast cancer xenografts. Cancer Res. 58, 2825-2831 (1998).
25. S-M. Huang, J. M. Bock and P. M. Harari, Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res. 59, 1935-1940 (1999).
26. P. Dent, W. D. Jarvis, M. J. Birrer, P. B. Fisher, R. K. Schmidt-Ullrich and S. Grant, The roles of signaling by the p42/44 mitogen activated protein kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity. Leukemia 12, 1843-1850 (1998).
27. D. B. Reardon, J. N. Contessa, R. B. Mikkelsen, K. Valerie, C. Amir, P. Dent and R. K. Schmidt-Ullrich, Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene 18, 4756-4766 (1999).
28. S. Carter, K. L. Auer, M. Birrer, P. B. Fisher, R. Schmidt-Ullrich, K. Valerie, R. Mikkelsen and P. Dent, Inhibition of mitogen activated protein kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene 16, 2787-2796 (1998).
29. O. Kashles, Y. Yarden, R. Fischer, A. Ullrich and J. A. Schlessinger, A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell Biol. 11, 1454-1463 (1991).
30. A. G. Batzer, P. Blaikie, K. Nelson, J. Schlessinger and B. Margolis, The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol. Cell Biol. 15, 4403-4409 (1995).
31. + in A431 human squamous carcinoma cells. J. Recept. Sig. Transd. Res. 19, 885-908 (1999).
32. M. Verheij, R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon and R. N. Kolesnick, Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 380, 75-79 (1996).
33. C. A. Kanashiro and R. A. Khalil, Signal transduclion by protein kinase C in mammalian cells. Clin. Exp. Pharmacol. Physiol. 25, 974-985 (1998).
34. 2-] in human epithelial tumor cells. Cancer Res. 54, 5224-5230 (1994).
35. C. S. Mason, C. J. Springer, R. G. Cooper, G. Superti-Furga, C. J. Marshall and R. Marais, Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J. 18, 2137-2148 (1999).
36. P. Dent, D. Reardon, D. K. Morrison and T. W. Sturgill, Regulation of Rat-1 and Raf-1 mutants by distinct GTP-dependent and GTP-independent mechanisms in vitro. Mol. Cell Biol. 15, 4125-4135 (1995).
37. P. Dent, T. Jelinek, D. K. Morrison, M. J. Weber and T. W. Sturgill, Reversal of Raf-1 activation by purified and membrane associated protein phosphatases. Science 268, 1902-1906 (1995).
38. L. Le Gallic, D. Sgouras, G. Beal, Jr. and G. Mavrothalassitis, Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation. Mol. Cell Biol. 19, 4121-4133 (1999).
39. M. Kuroki and J. T. O'Flaherty, Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines. Biochem. J. 341, 691-696 (1999).
40. M. V. Blagosklonny, Y. Chuman, R. C. Bergan and T. Fojo, Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells. Leukemia 13, 1028-1036 (1999).
41. P. Navarro, A. M. Valverde, M. Benito and M. Lorenzo, Activated Ha-ras induces apoptosis by association with phosphorylated bcl-2 in a mitogen-activated protein kinase-independent manner. J. Biol. Chem. 274, 18857-18863 (1999).
42. 2/M checkpoint arrest in cells exposed to ionizing radiation. J. Biol. Chem. 274, 2732-2742 (1999).
43. J. Vrana, S. Grant and P. Dent, Inhibition of the MAPK pathway abrogates BCL2-mediated survival of leukemia cells after exposure to low-dose ionizing radiation. Radiat. Res. 151, 559-569 (1999).
44. E. J. Bernhard, W. G. McKenna, A. D. Hamilton, S. M. Sebti, Y. Qian, J. M. Wu and R. J. Muschel, Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes. Cancer Res. 58, 1754-1761 (1998).
45. P.C. Gokhale, D. McRae, B. P. Monia, A. Bagg, A. Rahman, A. Dritschilo and U. Kasid, Antisense raf oligodeoxyribonucleotide is a radiosensitizer in vivo. Antisense Nucleic Acid Drug Dev. 9, 191-201 (1999).
46. B. D. Kavanagh, P. Dent, R. K. Schmidt-Ullrich, P. Chen and R. B. Mikkelsen, Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. Radiat. Res. 149, 579-587 (1998).
47. R. Tombes, K. L. Auer, S. Brenz-Verca, C. J. Marshall, M. McMahon, R. Mikkelsen, K. Valerie, M. P. Wymann and P. Dent, The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem. J. 330, 1451-1460 (1998).
48. Cip-1/WAI-1-null mice, but not in hepatocytes from p16 INK4a-null mice. Biochem. J. 336, 551-560 (1998).
49. Cip1. Mol. Cell Biol. 17, 5588-5597 (1997).
50. Cip1. Mol. Cell Biol. 17, 5598-5611 (1997).
51. R. J. Fiddes, P. W. Janes, S. P. Sivertsen, R. L. Sutherland, E. A. Musgrove and R. J. Daly, Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells. Oncogene 16, 2803-2813 (1998).
52. K. F. Macleod, N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein and T. Jacks, p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9, 935-944 (1995).
53. -/ mice. Mol. Cell Biol. 18, 4385-4390 (1998).
54. 1 checkpoint control. Cell 82, 675-684 (1995).
55. R. Y. C. Poon, M. S. Chau, K. Yamashita and T. Hunter, The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57, 5168-5178 (1997).
56. S. D. Leach, C. D. Scatena, C. J. Keefer, H. A. Goodman, S. Y. Song, L. Yang and J. A. Pietenpol, Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Cancer Res. 58, 3231-3236 (1998).
57. T. Kohayashi and P. Cohen, Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem. J. 339, 319-328 (1999).
58. M. Shaw, P. Cohen and D. R. Alessi, Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett. 416, 307-311 (1997).
59. C. Magnusson and D. L. Vaux, Signaling by CD95 and TNF receptors: Not only life and death. Immunol. Cell Biol. 77, 41-46 (1999).
60. R. J. Davis, Signal transduction by the c-Jun N-terminal kinase. Biochem. Soc. Symp. 64, 1-12 (1999).
61. S. J. Chmura, H. J. Mauceri, S. Advani, R. Heimann, E. Nodzenski, J. Quintans, D. W. Kufe and R. R. Weichselbaum, Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor cell killing by ionizing radiation. Cancer Res. 57, 4340-4347 (1997).
62. A. Haimovitz-Friedman, Radiation-induced signal transduction and stress response. Radiat. Res. 150 (Suppl), S102-S108 (1998).
63. S. Mathias, L. A. Pena and R. N. Kolesnick, Signal transduction of stress via ceramide. Biochem. J. 335, 465-480 (1998).
64. K. Auer, J. Contessa, S. Brenz-Verca, L. Pirola, S. Rusconi, G. Cooper, A. Abo, M. Wymann, R. J. Davis and P. Dent, The Ras/Rac1/ Cdc-42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Mol. Biol. Cell. 9, 561-573 (1998).
65. O. Potapova, A. Haghighi, F. Bost, C. Liu, M. J. Birrer, R. Gjerset and D. Mercola, The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272, 14041-14044 (1997).
66. 1 phase of the cell cycle. J. Cell Biol. 145, 1461-1469 (1999).
67. Y. A. Hannun, Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855-1899 (1996).
68. D. J. Sillence and D. Allan, Evidence against an early signaling role for ceramide in FAS-mediated apoptosis. Biochem. J. 324, 29-32 (1997).
69. N. Karasavvas and Z. Zakeri, Relationships of apoptotic signaling mediated by ceramide and TNFa in U937 cells. Cell Death Differ. 6, 115-123 (1999).
70. K. A. Dressler, S. Mathias and R. N. Kolesnick, TNF-α activates the sphingomyelin pathway in a cell free system. Science 255, 1715-1718 (1992).
71. J. G. Reyes, I. G. Robayna, P. S. Delgado, I. H. Gonzalez, J. Q. Aguiar, F. E. Rosas, L. F. Fanjul and C. M. R. Galaretta, c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells. J. Biol. Chem. 271, 21375-21380 (1996).
72. Y. Zhang, B. Yao, S. Delikat, S. Bayoumy, X. H. Lin, S. Basu, M. McGinley, P. Y. Chan-Hui, H. Lichenstein and R. Kolesnick, Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89, 63-72 (1997).
73. G. Muller, M. Ayoub, P. Storz, J. Rennecke, D. Fabbro and K. Pfizenmaier, PKC zeta is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14, 1961-1969 (1995).
74. WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res. 56, 31-35 (1996).
75. I. Stancovski and D. Baltimore, NF-κB activation: the IκB kinase revealed? Cell 91, 299-302 (1997).
76. W. C. Liao, A. Haimovitz-Friedman, R. S. Persaud, M. McLoughlin, D. Ehleiter, N. Zhang, M. Gatei, M. Lavin, R. Kolesnick and Z. J. Fuks, Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase. J. Biol. Chem. 274, 17908-17917 (1999).
77. A. Ashkenazi and V. M. Dixit, Death receptors: Signaling and modulation. Science 281, 1305-1308 (1998).
78. N. A. Thornberry and Y. Lazenbik, Caspases: The enemy within. Science 281, 1312-1316 (1998).
79. S. Basu, S. Bayoumy, Y. Zhang, J. Lozano and R. Kolesnick, BAD enables ceramide to signal apoptosis via Ras and Raf-1. J. Biol. Chem. 273, 30419-30426 (1998).
80. L. Cell 87, 619-628 (1996).
81. D. M. Farschon, C. Couture, T. Mustein and D. D. Newmeyer, Temporal phases in apoptosis defined by the actions of Src homology-2 domain, ceramide, Bcl-2, interleukin-1β family member proteases and a dense membrane fraction. J. Cell Biol. 137, 1117-1125 (1997).
82. S. A. Susin, N. Zamzami and G. Kroemer, Mitochondria as regulators of apoptosis: Doubt no more. Biochim. Biophys. Acta 1366, 151-165 (1998).
83. J. Yang, X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones and X. Wang, Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275, 1129-1132 (1997).
84. M. S. Sheikh, T. F. Burns, Y. Huang, G. S. Wu, S. Amundson, K. S. Brooks, A. J. Fornace and W. S. el-Deiry, p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res. 58, 1593-1598 (1998).
85. J. M. McDonnell, D. Fushman, C. L. Milliman, S. J. Korsmeyer and D. Cowburn, Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists. Cell 96, 625-634 (1999).
86. C. Stroh and K. Schulze-Osthoff, Death by a thousand cuts: An ever increasing list of caspase substrates. Cell Death Differ. 5, 997-1000 (1998).
87. S. E. Morgan and M. B. Kastan, p53 and ATM: Cell cycle, cell death, and cancer. Adv. Cancer Res. 71, 1-25 (1997).
88. A. J. Giaccia and M. B. Kastan, The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev. 12, 2973-2983 (1998).
89. 1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54, 5054-5058 (1994).
90. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein and R. W. Craig, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
91. M. B. Kastan, Q. Zhan, W. S. el-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein and A. J. Fornace, Jr., A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597 (1992).
92. S. J. Kuerbitz, B. S. Plunkett, W. V. Walsh and M. B. Kastan, Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA. 89, 7491-7495 (1992).
93. J. D. Siliciano, C. E. Canman, Y. Taya, K. Sakaguchi, E. Appella and M. B. Kastan, DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11, 3471-3481 (1997).
94. S. Banin, L. Moyal, S. Shieh, Y. Taya, C. W. Anderson, L. Chessa, N. I. Smorodinsky, C. Prives, Y. Reiss and Y. Ziv, Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677 (1998).
95. J. M. Lee and A. Bernstein, p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA 90, 5742-5746 (1993).
96. E. C. Friedberg, G. C. Walker and W. Siede, DNA Repair and Mutagenesis, pp. 662-668. ASM Press, Washington, DC, 1995.
97. K. K. Khanna, H. Beamish, R. Williams, P. Chen and M. F. Lavin, Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem. 271, 20486-20493 (1996).
98. K. K. Khanna, K. E. Keating, S. Kozlov, S. Scott, M. Gatei, K. Hobson, Y. Taya, B. Gabrielli, D. Chan and M. F. Lavin, ATM associates with and phosphorylates p53: Mapping the region of interaction. Nat. Genet. 20, 398-400 (1998).
99. M. J. Waterman, E. S. Stavridi, J. L. Waterman and T. D. Halazonetis, ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet. 19, 175-178 (1998).
100. K. Savitsky, A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D. A. Tagle, S. Smith, T. Uziel and S. Sfez, A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753 (1995).
101. K. Savitsky, S. Sfez, D. A. Tagle, Y. Ziv, A. Sartiel, F. S. Collins, Y. Shiloh and G. Rotman, The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet. 4, 2025-2032 (1995).
102. M. Jung, A. Kondratyev, S. A. Lee, A. Dimtchev and A. Dritschilo, ATM gene product phosphorylates Iκβ-α. Cancer Res. 57, 24-27 (1997).
103. G. Chen and E. Lee, The product of the ATM gene is a 370-kDa nuclear phosphoprotein. J. Biol. Chem. 271, 33693-33697 (1996).
104. M. Jung, Y. Zhang, S. Lee and A. Dritschilo, Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated Iκβ-α. Science 268, 1619-1621 (1995).
105. R. Baskaran, L. D. Wood, L. L. Whitaker, C. E. Canman, S. E. Morgan, Y. Xu, C. Barlow, D. Baltimore, A. Wynshaw-Boris and J. Y. Wang, Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516-519 (1997).
106. K. K. Khanna, J. Yan, D. Watters, K. Hohson, H. Beamish, K. Spring, Y. Shiloh, R. A. Gatti and M. F. Lavin, Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells. J. Biol. Chem. 272, 9489-9495 (1997).
107. T. Shafman, K. K. Khanna, P. Kedar, K. Spring, S. Kozlov, T. Yen, K. Hobson, M. Gatei, N. Zhang and M. F. Lavin, Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387, 520-523 (1997).
108. M. Arcinas, K. C. Sizer and L. M. Boxer, Activation of c-myc expression by c-Abl is independent of both the DNA binding function of c-Abl and the c-myc EP site. J. Biol. Chem. 269, 21919-21924 (1994).
109. Z. M. Yuan, Y. Huang, Y. Whang, C. Sawyers, R. Weichselbaum, S. Kharbanda and D. Kufe, Role for c-Abl tyrosinc kinase in growth arrest response to DNA damage. Nature 382, 272-274 (1996).
110. S. Kharbanda, R. Ren, P. Pandey, T. D. Shafman, S. M. Feller, R. R. Weichselbaum and D. W. Kufe, Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376, 785-788 (1995).
111. T. D. Shafman, A. Saleem, J. Kyriakis, R. Weichselbaum, S. Kharbanda and D. W. Kufe, Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation. Cancer Res. 55, 3242-3245 (1995).
112. Y. Sanchez, B. A. Desany, W. J. Jones, Q. Liu, B. Wang and S. J. Elledge, Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science 271, 357-360 (1996).
113. B. Furnari, N. Rhind and P. Russell, Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277, 1495-1497 (1997).
114. Y. Sanchez, C. Wong, R. S. Thoma, R. Richman, Z. Wu, H. Piwnica-Worms and S. J. Elledge, Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25. Science 277, 1497-1501 (1997).
115. N. C. Walworth and R. Bernards, rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science 211, 353-356 (1996).
116. A. L. Brown, C. H. Lee, J. K. Schwarz, N. Mitiku, H. Piwnica-Worms and J. H. Chung, A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 96, 3745-3750 (1999).
117. S. Matsuoka, M. Huang and S. J. Elledge, Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893-1897 (1998).
118. G. J. Den Haese, N. Walworth, A. M. Carr and K. L. Gould, The Wee1 protein kinase regulates T14 phosphorylation of fission yeast Cdc2. Mol. Biol. Cell 6, 371-385 (1995).
119. 2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J. 16, 545-554 (1997).
120. 2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-1505 (1997).
121. G. Chen, S. S. Yuan, W. Liu, Y. Xu, K. Trujillo, B. Song, F. Cong, S. P. Goff, Y. Wu and E. Y. Lee, Radiation-induced assembly of rad51 and rad52 recombination complex requires. ATM and c-Abl. J. Biol. Chem. 274, 12748-12752 (1999).
122. 2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells. Oncogene 18, 249-256 (1999).
123. S. Kharbanda, Z. M. Yuan, R. Weichselbaum and D. Kufe, Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene 17, 3309-3318 (1998).
124. M. Yuan, Y. Huang, T. Ishiko, S. Nakada, T. Utsugisawa, S. Kharbanda, R. Wang, P. Sung, A. Shinohara and D. Kufe, Regulation of Rad51 function by c-Abl in response to DNA damage. J. Biol. Chem. 273, 3799-3802 (1998).
125. M. Fritsche, C. Haessler and G. Brandner, Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8, 307-318 (1993).
126. W. S. el-Deiry, T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler and B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
127. Y. Barak, T. Juven, R. Haffner and M. Oren, mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468 (1993).
128. L. Smith, I. T. Chen, Q. Zhan, I. Bae, C. Y. Chen, T. M. Gilmer, M. B. Kastan, P. M. O'Connor and A. J. Fornace, Jr., Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266, 1376-1380 (1994).
129. R. Li, S. Waga, G. J. Hannon, D. Beach and B. Stillman, Differential effects by the p21 CDK inhibitor on PCNA-depcndcnt DNA replication and repair. Nature 371, 534-537 (1994).
130. S. Waga, G. J. Hannon, D. Beach and B. Stillman, The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578 (1994).
131. J. Momand, G. P. Zambetti, D. C. Olson, D. George and A. J. Levine, The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245 (1992).
132. M. Reed, B. Woelker, P. Wang, Y. Wang, M. E. Anderson and P. Tegtmeyer, The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc. Natl. Acad. Sci. USA 92, 9455-9459 (1995).
133. G. Bakalkin, G. Selivanova, T. Yakovleva, E. Kiseleva, E. Kashuba, K. P. Magnusson, L. Szekely, G. Klein, L. Terenius and K. G. Wiman, p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. Nucleic Acids Res. 23, 362-369 (1995).
134. S. P. Lees-Miller, K. Sakaguchi, S. J. Ullrich, E. Appella and C. W. Anderson, Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell Biol. 12, 5041-5049 (1992).
135. T. M. Gottlieb and S. P. Jackson, The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 72, 131-142 (1993).